Opioid analgesics suppress male gonadal function, but opioid use in men and women does not correlate with symptoms of sexual dysfunction

Pain Research and Management

Volumn 16, Issue 5, 2011, Pages 311-316

  Wong, Dana ^a   Gray, Dan ^a   Simmonds, Mark ^a   Rashiq, Saifee ^a   Sobolev, Igor ^a   Morrish, Donald W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Gonadal dysfunction; Opioid analgesia; Pain syndromes; Sexual functioning

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; OPIATE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; HYPOPHYSIS HORMONE; NARCOTIC ANALGESIC AGENT; SEX HORMONE;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG USE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONAD FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PREMENOPAUSE; PROLACTIN BLOOD LEVEL; PROSPECTIVE STUDY; SEXUAL DYSFUNCTION; TESTOSTERONE BLOOD LEVEL; METABOLISM; MIDDLE AGED; OPIATE ADDICTION; PATHOPHYSIOLOGY; PSYCHOSEXUAL DISORDER; SEX DIFFERENCE; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC PAIN; FEMALE; GONADAL HORMONES; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PITUITARY HORMONES; PROLACTIN; PROSPECTIVE STUDIES; SEX FACTORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; STATISTICS AS TOPIC;

EID: 84555196161     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/807123     Document Type: Article

References (19)

1. National Center for Health Statistics. Health, United States, 2006: With Chartbook on Trends in the Health of Americans. Hyattsville: NCHS, 2006:68-71. 〈www.222.cdc.gov/nchs/data/hus/hus06.pdf〈 (Accessed on July 5, 2010).
2. Gallagher RM, Rosenthal LJ. Chronic pain and opiates: Balancing pain control and risks of long-term opioid treatment. Arch Phys Med Rehabil 2008;89:S77-82. (Pubitemid 351754812)
3. Van Den Kerkhof EG, Hopman WM, Towheed TE, Anastassiades TP, Goldstein DH; Canadian Multicentre Osteoporosis Study Research Group. The impact of sampling and measurement on the prevalence of self-reported pain in Canada. Pain Res Manag 2003;8:157-63. (Pubitemid 37461199)
4. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002;3:377-84. (Pubitemid 35176459)
5. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000;283:1710-4. (Pubitemid 30196211)
6. Vuong C, Van Uum SHM, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010;31:98-132.
7. Adams ML, Sewing B, Forman JB, Meyer ER, Cicero TJ. Opioid-induced suppression of rat testicular function. J Pharmacol Exp Ther 1993;266:323-8. (Pubitemid 23315665)
8. Giri M, Kaufman JM. Opioidergic modulation of in vitro pulsatile gonadotropin-releasing hormone release from the isolated medial basal hypothalamus of the male guinea pig. Endocrinology 1994;135:2137-43. (Pubitemid 24363912)
9. Daniell HW. DHEAS deficiency during consumption of sustained-action prescribed opioid - evidence for opioid-induced inhibition of adrenal androgen production. J Pain 2006;7:901-7. (Pubitemid 44854733)
10. Fraser LA, Morrison D, Morley-Forster P, et al. Oral opioids for chronic non-cancer pain: Higher prevalence of hypogonadism in men than in woman. Exp Clin Endocrinol Diabetes 2009;117:38-43.
11. Azizi F, Vagenakis AG, Longcope C, Ingbar SH, Braverman LE. Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids 1973;22:467-72.
12. Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of non-malignant pain. J Pain 2008;9:28-36. (Pubitemid 350309727)
13. Rajagopal A, Vassilopoulou-Sellin R, Palmer HL, Kaur G, Bruera E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manag 2003;25:1055-61. (Pubitemid 37324686)
14. Pereira J, Bruera E. Alberta Hospice Palliative Care Resource Manual, 2nd edn. Edmonton: Alberta Cancer Board, 2001:1-88. 〈www.palliative.org/PC/ ClinicalInfo/ACB%20PC%20resource%20manual.pdf〉 (Accessed on July 5, 2011).
15. Moshtaghi-Kashanian GR, Esmaeeli F, Dabiri S. Enhanced prolactin levels in opium smokers. Addict Biol 2005;10:345-9. (Pubitemid 41759269)
16. Rasheed A, Tareen IA. Effects of heroin on thyroid function, cortisol and testosterone level in addicts. Pol J Pharmacol 1995;47:441-4.
17. Guay A, Jacobson J, Talakoub L, Traish A, Quirk F, Spark R. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction. Int J Imp Res 2004;16:112-20. (Pubitemid 38579455)
18. Guay A, Jacobson J, Munarriz R, et al. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B. Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. Int J Imp Res 2004;16:121-9. (Pubitemid 38579456)
19. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gyncol 2005;105:944-52. (Pubitemid 40571010)